Fact Check: The Trump Administration’s Stance on Paracetamol (Tylenol) and Autism Risk
TLDR (Too Long; Didn’t Read)
President Donald Trump recently urged pregnant women to avoid or limit acetaminophen (Paracetamol/Tylenol), claiming it heightens the risk of autism. The current, conclusive scientific consensus does not support this declaration. Major global health bodies (WHO, UK MHRA, US medical associations) reject a causal link. They warn that avoiding the medication for necessary treatment poses greater health risks to both mother and fetus. This is especially true in cases of high fever. Acetaminophen remains the safest pain and fever treatment recommended for use in pregnancy when medically needed. Always consult your doctor.
Decoding the Declaration: What Was Said About Tylenol, Paracetamol, and Autism
On Monday, September 22, 2025, President Donald Trump, alongside officials including Health Secretary Robert F. Kennedy Jr., made a controversial public statement. He urged pregnant women to drastically limit their use of acetaminophen. It is widely known in the US as Tylenol and globally as Paracetamol.
The President repeatedly warned the public, stating, “Don’t take Tylenol,” and suggested that the drug contributes to rising autism rates. He advised women to use the medication only for high fever. He suggested using it if they “can’t tough it out.” This implies a strong, direct connection between prenatal exposure and the development of Autism Spectrum Disorder (ASD).
The Swift Scientific Backlash: Consensus Rejects a Causal Link
The announcement prompted immediate and strong criticism from leading international and national medical institutions. The scientific and medical community overwhelmingly agrees. They assert that a causal link between acetaminophen use in pregnancy and autism has not been proven.
- Global Health Authorities: The World Health Organization (WHO), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and the Australian Therapeutic Goods Administration (TGA) each made public affirmations. They all confirmed their positions. Current scientific evidence does not support the claim that paracetamol use during pregnancy causes autism.
- Leading US Medical Societies: Groups like the Society for Maternal-Fetal Medicine (SMFM) and the American College of Obstetricians and Gynecologists (ACOG) reiterated their guidance. Acetaminophen is one of the few safe options for treating fever and pain during pregnancy. Leaving these conditions untreated can pose significant maternal and infant health risks. These risks include miscarriage, birth defects, and premature birth.
- Autism Researchers: The Autism Science Foundation condemned the assertion as “not scientifically based.” It is potentially “misleading to families.” The foundation stressed that autism is a complex condition primarily dictated by genetic factors.
Examining the Evidence: Association vs. Causation
The debate stems from a body of scientific literature that is conflicting.
Studies Suggesting an Association
Some older or smaller observational studies have suggested a statistical association. They observe that frequent or prolonged use of acetaminophen during pregnancy has a link to a small increase in the risk of certain neurodevelopmental issues. These issues include ASD and ADHD. These studies often rely on self-reported data and cannot prove that the drug caused the condition—the association could be explained by other factors, such as the underlying reasons for taking the painkiller (e.g., chronic illness, stress, or the effects of the fever/inflammation itself).
The Most Robust Evidence Rejects a Causal Link
The most rigorous research has found no evidence of a causal relationship.
The largest and most methodologically sound study to date, published in JAMA in 2024, analyzed data from over 2.4 million births in Sweden, including a key sibling control group. Researchers compared siblings. Only one was exposed to paracetamol in utero. This method allowed them to account for shared genetic and environmental factors. This analysis found no increased risk of autism, ADHD, or intellectual disability linked to prenatal paracetamol exposure.
Current Medical Advice
The official guidance from the FDA, medical associations, and global bodies remains consistent:
- Acetaminophen is the Safest Option: It is the recommended first-line treatment for pain and fever during pregnancy.
- Use Only When Necessary: Pregnant individuals should use the medication at the lowest effective dose. They should use it for the shortest possible duration, as with any drug during pregnancy.
- Consult Your Physician: It is crucial to discuss any pain, fever, or medication use with a healthcare provider.
Frequently Asked Questions (FAQ)
| Question | Answer |
| Did President Trump declare that Paracetamol/Tylenol causes autism? | Yes, he publicly advised pregnant women to avoid it, claiming it heightens the risk of autism. |
| Is the President’s claim supported by conclusive science? | No. Major global and national medical organizations have stated that current, robust scientific evidence does not support a causal link. |
| Is Paracetamol (Acetaminophen) still safe to take during pregnancy? | Yes, when used correctly. It is the safest over-the-counter pain and fever reliever recommended for pregnant women. Use the lowest dose for the shortest time necessary. |
| What are the risks of not treating fever during pregnancy? | Untreated high fever can pose significant dangers, including an increased risk of miscarriage, birth defects, and premature birth. |
| What do the most rigorous studies show about the link? | The largest and most reliable studies, like the 2024 Swedish sibling study, found no causal link between prenatal acetaminophen exposure and autism. |
Export to Sheets
10 Real Sources for Evidence-Based Regarding Paracetamol and Autism
The following are key sources of scientific evidence and official medical guidance on this issue:
- Swedish Sibling Control Study (2024) JAMA article, April 2024
- World Health Organization (WHO) Statement (Sept 2025) WHO statement, September 2025
- Society for Maternal-Fetal Medicine (SMFM) Recommendation SMFM statement, September 2025 SMFM statement, September 2025 (alternative official release)
- American College of Obstetricians and Gynecologists (ACOG) Position ACOG official guidance, August 2025 ACOG physician FAQ (background) ACOG response to consensus statement
- UK Medicines and Healthcare products Regulatory Agency (MHRA) Stance MHRA official statement, September 2025
- FDA Notice to Physicians (Sept 2025) FDA notice PDF, September 2025 FDA press release on association and clinical perspective
- Mount Sinai/Harvard Systematic Review (Aug 2025) Mount Sinai press release, August 2025 Politico interview with co-author
- Australian Therapeutic Goods Administration (TGA) Statement TGA confirmation and analysis, September 2025 Autism CRC statement and details
- Scientific Commentary from the Autism Science Foundation Yale commentary on conflicting science
- General Consensus on Autism Etiology Nature summary: Genetics and multifactorial origins
